• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

10 Devices that Could Pose Problems for Patients with ICDs

News
Slideshow

Modern ICDs have built-in protection from interference by most current technologies. But do you know which ones could be problematic for your patients?

slideshow image

Implantable cardioverter defibrillators are at very low risk of interference from the majority of electrical devices your patients encounter and employ in daily life. But there are a number of popular personal devices (eg, cell phones, MP3 players and headphones) as well as medical instruments (eg, MRI, TENS) that could be a problem.

Click through the slides above for a quick look at 10 devices you'll want to discuss with any patient who has an ICD.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Impact of Social Determinants of Health on Key Cardiometabolic Measures Amplified by New Research
Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
Intermediate Cardiometabolic Risk: Study Author Explains this "Critical Inflection Point"
US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
US Cardiometabolic Health at Alarming Suboptimal Levels, Says Lead Author of New NHANES Analysis
Beyond HbA1c: Take a Global Approach to Type 2 Diabetes Management, Use all the Tools
Beyond HbA1c: Take a Global Approach to Type 2 Diabetes Management, Use all the Tools
VA Clinical Investigator Discusses HbA1c, Comorbidities as Markers for T2D Treatment Intensification
VA Clinical Investigator Discusses HbA1c, Comorbidities as Markers for T2D Treatment Intensification
Kidney Outcomes with Tirzepatide in T2D: Hiddo Heerspink, PhD, PharmD Highlights SURPASS-4 Analysis
Kidney Outcomes with Tirzepatide in T2D: Hiddo Heerspink, PhD, PharmD Highlights SURPASS-4 Analysis
Is There Room for TikTok in Medicine? A Young Clinician Explains
Is There Room for TikTok in Medicine? A Young Clinician Explains
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
SGLT-2 Inhibitors Belong to Patients, Not a Specialty or Primary Care: Experts Discuss
SGLT-2 Inhibitors Belong to Patients, Not a Specialty or Primary Care: Experts Discuss
Quality of HTN-related Videos on TikTok: Study Author Shares Findings
Quality of HTN-related Videos on TikTok: Study Author Shares Findings
Related Content
Cardiovascular Health

Only 1 in 5 Women Meet Heart Health Targets at Midlife, and These 4 Factors Matter Most

Grace Halsey
August 4th 2025
Article

Adequate sleep tops the 4 elements most important to CV health after menopause, with blood pressure, glucose levels, and smoking status close behind.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
July 8th 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Tirzepatide Proves Noninferiority with Dulaglutide for MACE in Lilly's Landmark Incretin Face-Off / image credit ©MichaelVI/stock.adobe.com

Tirzepatide Proves Noninferiority With Dulaglutide for MACE in Lilly's Landmark Incretin Face-Off

Grace Halsey
August 1st 2025
Article

In the SURPASS-CVOT trial, tirzepatide reduced MACE-3 by 8% and all-cause mortality by 16% compared with dulaglutide, while also reducing HbA1c and weight.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Sydney Jennings
August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns

GLP-1 Therapy for Obesity Requires Substantial Nutritional Framework, Multidisciplinary Support, Joint Advisory Warns

Grace Halsey
July 9th 2025
Article

GLP-1 medications are transforming obesity medicine but strong evidence points to a need for integrating nutrition and lifestyle support for lasting weight loss and health benefits.

BF% outperforms BMI in Predicting Morality risk in young adults: New Findings / image courtesy of University of Florida

Body Fat Percentage Outperforms BMI in Predicting Mortality Risk in Young Adults: New Findings

Grace Halsey
July 8th 2025
Article

Body fat percentage and waist circumference were both significantly associated with 15-year all-cause mortality while BMI had no significant association.

© 2025 MJH Life Sciences

All rights reserved.